By ETF Desk
Manipal Health has received the Securities and Exchange Board of India’s (SEBI) nod to proceed with its initial public offering (IPO), allowing the company to list its shares on Indian stock exchanges.
The Bangalore‑based healthcare group, known for its innovative pharmaceutical research and manufacturing facilities, submitted its listing documents earlier this year. SEBI’s approval came after a thorough scrutiny of the company’s financials, corporate governance and environmental compliance. The listing is slated to commence on the National Stock Exchange (NSE) later this quarter.
For the Udupi region, the approval signals growing confidence in the regional pharma ecosystem. Local investors, entrepreneurs and research institutions in and around Udupi are watching Manipal Health’s IPO as a benchmark for potential investment opportunities and employment prospects in the healthcare sector. Source: Google News – Manipal.